Molecular genetic polymorphisms C786T of the eNOS gene and LYS198ASN of the END1 gene in diabetic foot syndrome
https://doi.org/10.18705/2311-4495-2022-9-4-13-19
Abstract
Background. Diabetic foot syndrome is one of the complications of diabetes mellitus, which could result in
the development of purulent-necrotic lesions of soft tissues or amputation. Nitric oxide and endothelin-1 plays key role in endothelium dysfunction, thus contributing to the pathogenesis.
Objective. To evaluate the frequency of genotypes of the C786T polymorphism of the eNOS gene and the LYS198ASN polymorphism of the END1 gene in a group of patients with diabetic foot syndrome and a group of healthy donors living in the Trans-Baikal Territory.
Design and methods. In 100 healthy individuals and 198 patients with a mixed form of diabetic foot syndrome, polymorphisms were studied by PCR. The statistical significance of differences was assessed using Pearson’s chi-square test.
Results. The C/C and T/T genotypes of the C786T polymorphism of the eNOS gene were more common in patients (1.2 times and 2.1 times, respectively), while the incidence of the C/T genotype was 1.4 times lower. The LYS/LYS genotype of the LYS198ASN polymorphism of the END1 gene was more frequently observed in the control group, while K/N and ASN/ASN genotype was detected 1.7 and 2.2 times more often in the patients, respectively.
Conclusion. Frequency differences in genotypes of the polymorphisms of eNOS and END1 genes in patients with diabetic foot syndrome and healthy individuals confirm their contribution to the endothelial dysfunction.
About the Authors
N. I. TroitskayaRussian Federation
Natalya I. Troitskaya, PhD, Associate Professor of the Department of Oncology
Gorky str., 39a, Chita, 672000
K. G. Shapovalov
Russian Federation
Konstantin G. Shapovalov, MD, Professor, Head of the Department of Anesthesiology, Intensive care and Intensive care
Chita
V. A. Mudrov
Russian Federation
Victor A. Mudrov, PhD, Associate Professor of the Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry
Chita
References
1. Dedov II, Shestakova MV. Complications of diabetes mellitus: treatment and prevention: monograph. M.: Medicinskoe informacionnoe agentstvo, 2017. p.744. In Russian [Дедов И.И., Шестакова М.В. Осложнения сахарного диабета: лечение и профилактика: монография. М.: Медицинское информационное агентство, 2017. 744 с.]
2. International Diabetes Federation (IDF). Diabetes Atlas. 7th Edition, International Diabetes Federation, Brussels, Belgium. http://www.diabetesatlas.org (2015)
3. Standards of Medical Care in Diabetes-2017: Summary of Revisions. Diabetes Care. 2017; 40(Suppl 1):S4-S5. DOI: 10.2337/dc17-S003.
4. Dedov II, Shestakova MV. Type 2 diabetes mellitus: from theory to practice. M.: Medicinskoe informacionnoe agentstvo, 2016. p. 576. In Russian [Дедов И.И., Шестакова М.В. Сахарный диабет типа 2: от теории к практике. М.: Медицинское информационное агентство, 2016. 576 с.]
5. Druk IV, Nechaeva GI, Rjapolova EA. Diabetic foot syndrome: tactics of preventive interventions. LechNhij vrach. 2014; 12:12-14. In Russian [Друк И.В., Нечаева Г.И., Ряполова Е.А. Синдром диабетической стопы: тактика профилактических вмешательств. Лечащий врач. 2014; 12:12–14.]
6. Tokmakova AY, Egorova DN, Doronina LP. Foot disorders in diabetes mellitus. Obesity and metabolism. 2017; 14(1):41–47. In Russian [Токмакова А.Ю., Егорова Д.Н., Доронина Л.П. Поражения нижних конечностей при сахарном диабете. Ожирение и метаболизм. 2017; 14(1):41–47.] DOI: 10.14341/omet2017141-47.
7. Kurlayev PP, Gritsenko VA, Belozertseva YP. Modern approaches to antibiotic therapy of purulentnecrotic complications of diabetic foot syndrome. Bjulleten’ Orenburgskogo nauchnogo centra UrO RAN. 2016; 2: 1–13. In Russian [Курлаев П.П., Гриценко В.А., Белозерцева Ю.П. Современные подходы к антибактериальной терапии гнойно-некротических осложнений синдрома диабетической стопы. Бюллетень Оренбургского научного центра УрО РАН. 2016; 2:1–13.]
8. Dubrovshchik OI, Garelik PV, Dovnar IS, et al. Real possibilities to decrease a quantity of lower extremities amputations in patients with purulo-necrotic complications of diabetic foot syndrome. Journal of the Grodno State Medical University. 2015; 4(52): 26–29. In Russian [Дубровщик О.И., Гарелик П.В., Довнар И.С. и др. Реальные возможности снижения частоты ампутаций нижних конечностей у пациентов с гнойно-некротическими осложнениями синдрома диабетической стопы. Журнал Гродненского государственного медицинского университета. 2015; 4(52): 26–29.]
9. Maksimova N. Diabetic foot syndrome: possible problems and solutions. Aktualnaya endokrinologiya. 2016; 3: 53–70. In Russian [Максимова Н. Синдром диабетической стопы: возможные проблемы и пути решения. Актуальная эндокринология. 2016; 3: 53–70.]
10. Korejba KA, Minabutdinov AR, Tueshev LM, et al. Diabetic foot syndrome. Replacement for inpatient treatment technique based on the fast track surgery. Ambulatornaya khirurgiya=Ambulatory Surgery (Russia). 2019;(1–2):72–79. In Russian [Корейба К.А., Минабутдинов А.Р., Туешев Л.М. и др. Синдром диабетической стопы. Стационарзамещающая методика на основе fast track-хирургии. Амбулаторная хирургия. 2019; (1– 2):72–79.] DOI: 10.21518/1995-1477-2019-1-2-72-79.
11. Wukich DK, Ahn J, Raspovic KM, et al. Comparison of Transtibial Amputations in Diabetic Patients With and Without End-Stage Renal Disease. Foot Ankle Int. 2017; 38(4):388–396. DOI: 10.1177/1071100716688073.
12. Berstneva SV, Dubinina II, Byalovsky YuYu, et al. Genetic aspects of diabetic neuropathy in the case of patients having dianetes mellitus of the 2nd type. Medical almanac. 2017; 6 (51): 140–144. In Russian [Берстнева С.В., Дубинина И.И., Бяловский Ю.Ю. и др. Генетические аспекты диабетической нефропатии у больных сахарным диабетом 2-го типа. Медицинский альманах. 2017; 6 (51): 140–144.]
13. Stepanova TV, Ivanov AN, Tereshkina NE, et al. Markers of endothelial dysfunction: pathogenetic role and diagnostic significance. Russian clinical laboratory diagnostics. 2019; 64(1): 34–41. In Russian [Степанова Т.В., Иванов А.Н., Терешкина Н.Е. и др. Маркеры эндотелиальной дисфункции: патогенетическая роль и диагностическое значение (обзор литературы). Клиническая лабораторная диагностика. 2019; 64(1): 34–41.] DOI: 10.18821/0869-2084-2019-64-1-34-41.
14. Davydchyk EV, Snezhitskiy VA, Stepuro TL, et al. Endothelial nitric oxide synthase gene G894T polymorphism in patients with coronary heart disease and diabetes mellitus type 2. Journal of the Grodno State Medical University. 2018; 16(6): 673–678. In Russian [Давыдчик Э.В., Снежицкий В.А., Степуро Т.Л. и др. Полиморфизм G894T гена эндотелиальной синтазы оксида азота у пациентов с ишемической болезнью сердца и сахарным диабетом 2 типа. Журнал Гродненского государственного медицинского университета. 2019; 16(6): 673–678.] DOI:10.25298/2221-8785-2018-16-6-673-678.
15. Mudrov VA. Statistical anaKis algorithms of qualitative features in biomedical research using the SPSS software package. Transbaikalian Medical Bulletin. 2020; 1:151–163. In Russian [Мудров В.А. Алгоритмы статистического анализа качественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; 1:151–163.] DOI: 10.52485/19986173_2020_1_151.
16. Zhao S, Li T, Zheng B, et al. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a metaanaKis. Ophthalmic Genet. 2012; 33(4):200–207. DOI: 10.3109/13816810.2012.675398.
17. Ezzidi I, Mtiraoui N, Mohamed MB, et al. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications. 2008; 22(5):331–338. DOI: 10.1016/j.jdiacomp.2007.11.011.
18. Šeruga M, Kariž S, Makuc J, et al. Endothelin-1 Gene Polymorphisms rs5370, rs1476046, and rs3087459 are not Associated with Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus. Folia Med (Plovdiv). 2017; 59(3):261–269. DOI: 10.1515/folmed-2017-0033.
19. Li H, Louey JW, Choy KW, et al. EDN1 K198N is associated with diabetic retinopathy in type 2 diabetes. Mol Vis. 2008 Sep 15;14:1698–1704.
Review
For citations:
Troitskaya N.I., Shapovalov K.G., Mudrov V.A. Molecular genetic polymorphisms C786T of the eNOS gene and LYS198ASN of the END1 gene in diabetic foot syndrome. Translational Medicine. 2022;9(4):13-19. (In Russ.) https://doi.org/10.18705/2311-4495-2022-9-4-13-19